Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-30T02:45:04.198Z Has data issue: false hasContentIssue false
  • English
  • Français

Prognosis in Schizophrenia

Published online by Cambridge University Press:  08 February 2018

Donald Blair
Donald Blair*
Affiliation:
Cane Hill Hospital
Get access Rights & Permissions [Opens in a new window]

Extract

In the world of mental diseases schizophrenia may well be termed “the sickness that destroyeth in the noonday.” Although the replacement of Kraepelin's nomenclature of “dementia praecox” by Bleuler's term, “schizophrenia,” has carried with it a general recognition that the chance of recovery is better than had been originally anticipated, the doom of those who do not recover is amongst the most dreadful meted out by any disease. It so frequently means a body apparently fully alive with a mind permanently impaired or virtually dead. Despite the obvious desirability of assessing the prognostic chances of the individual case, the statistical works published up to date have failed to establish agreement as to how this may be done. The object of this paper is to combine a detailed examination of the literature with a personal study of the histories of over 100 cases of schizophrenia in an effort to reach a definite conclusion in this matter. The paper will be divided into the following parts: I, a detailed survey of the literature; II, the outcome of 120 cases studied by myself; III, a comparison of remission rates and prognostic factors in cases treated by cardiazol.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 86 , Issue 362 , May 1940 , pp. 378 - 477
Copyright
Copyright © Royal College of Psychiatrists, 1940 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albrecht, (1905), “Zur Symptomatologie der Dementia Praecox,” Allg. Z. Psychiat., 62, 659, 686.Google Scholar
Angyal, and Gyarfas, (1936), Arch. f. Psychiat., 106, 1.Google Scholar
Arnesen, (1937), Tidsskr. Norske Laegeforen., 569.Google Scholar
Barrett, Albert M. (1928), “Heredity Relations in Schizophrenia,” Proc. Assoc. Res. Ment. and Nerv. Dis., 5, 67.Google Scholar
Beckenstein, N. (1939), “Results of Metrazol Therapy in Schizophrenia,” Psychiat. Quart., 13, 106–113, January.Google Scholar
Bellinger, C. H. (1932), “Prognosis in Schizophrenia-Catatonia,” ibid., 6, 475–487.Google Scholar
Idem (1939), during a discussion on Metrazol Therapy.Google Scholar
Bennett, and Fitzpatrick, (1939), “Fractures of the Spine Complicating Metrazol Treatment,” Journ. Amer. Med. Assoc., 112, 2240–2244, June, 1939.CrossRefGoogle Scholar
Beno, N. (1938), “Observation and Results in Insulin Treatment,” Amer. Journ. Psychiat. (Supp.), 94, 213–219, May, 1938.CrossRefGoogle Scholar
Bianchi, (1928), quoted by Menninger, (1928).Google Scholar
Bleuler, E. (1930), “The Physiogenic and Psychogenic in Schizophrenia,” Amer. Journ. of Psychiat., 10, No. 2, September.Google Scholar
Idem (1936), Textbook of Psychiatry, translated by Brill, A. A. New York: Macmillan & Co.Google Scholar
Blair, Donald (1940), “Fractures and Injuries of the Vertebrae in Cardiazol and Epileptic Convulsions,” Lancet, 1940. (In the course of publication.) Google Scholar
Bond, E. D. (1921), “A Review of the 5-year Period following Admission in in Mental Patients,” Amer. Journ. Insan., 77, 385–394.Google Scholar
Idem (1921), “Results in 251 Cases 5 Years after Admission to a Hospital for Mental Diseases,” Arch. Neurol. and Psychiat., 6, 429–439.Google Scholar
Idem and Braceland, F. J. (1937), “Prognosis in Mental Disease. Use of one page abstracts,” Amer. Journ. Psychiat., 94, 263–274.Google Scholar
Bowman, M., and Raymond, A. F. (1929), “Physical Findings in Schizophrenia,” Amer. Journ. Psychiat., 8, 901–913 (1929),CrossRefGoogle Scholar
Braatoy, T. (1936), “The Prognosis in Schizophrenia, with some Remarks regarding Diagnosis and Therapy,” Ada. Psychiat. et Neurol., 11, 1.Google Scholar
Bresowsky, M. (1928), “Zur Frage der Heilbarkeit der Dementia Praecox,” Monatsschr. Psychiat. Neurol., 68, 125–136.CrossRefGoogle Scholar
Brill, A. A. (1928), “The Schizoid Concept in the Neuroses and Psychoses,” Proc. Assoc. Res. Ment. and Nerv. Dis., 5, 31.Google Scholar
Briner, O. (1937), “Results of the Convulsion Therapy in the Psychiatric Clinic in Berne,” Amer. Journ. Psychiat., 94, supplement on 1937 Berne-Munsingen Congress, 167.Google Scholar
Idem (1938), “Untersuchung über die Art und Häufigkeit der Remissionen bei Schizophrenie mit besonderer Berücksichtigung der Frühentlassungen und der Dauerschlaftherapie,” Zeitschr. f. d. ges. Neur. u. Psychiat., 162, 582–597.CrossRefGoogle Scholar
Carp, Louis (1939), “Fractures and Dislocations by Muscular Violence Complicating Convulsions Induced by Metrazol for Schizophrenia,” Amer. Surg., 110, 1, 107, July.Google Scholar
Cohen, L. (1938), “The Early Effects of Metrazol Therapy,” Amer. Journ. Psychiat., 95, 327–337, September.CrossRefGoogle Scholar
Coles, W. W., and Fuller, L. C. (1909), A Statistical Study of 109 Cases of Dementia Praecox. Google Scholar
Cook, L. C. (1938), “Cardiazol Convulsion Therapy in Schizophrenia,” Proc. Roy. Soc. Med., 21, 567–577.CrossRefGoogle Scholar
Dhanjbhoy, (1938), Lancet, 1, 370.CrossRefGoogle Scholar
Diem, Otto (1903), “Die einfache demente form der Dementia Praecox (Dementia Simplex),” Arch. f. Psychiat. u. Nervenkr., 37 Bund.Google Scholar
Dussik, K. T. (1936), Roczn. Psychiat., 28, 42, cf. (1937), Zentralbl. Neur. Psychiat., 26, 653.Google Scholar
Idem and Sakel, M. (1936), “Ergebnisse und Grenzen der Hypoglycämieshockbehandlung der Schizophrenie,” Zeitschr. f. d. ges. Neur. u. Psychiat., 155, 3, 351–415.Google Scholar
Ederle, W. (1937), Munch. med. Wochenschr., ***, 1811.Google Scholar
Ellery, R. S. (1937), “Schizophrenia and its Treatment by Insulin and Cardiazol,” Med. Journ. Austral., 552–564, October.CrossRefGoogle Scholar
Evensen, (1937), quoted by Langfeldt, .Google Scholar
Faurbye, A. (1937), “Statistical Data and Prognosis of Schizophrenia,” Norsk. Med. Tidskr., 13, 206–207, February 6, 1937.Google Scholar
Finkleman, I., Steinberg, L., and Liebert, E. (1938), “Treatment of Schizophrenia with Metrazol,” Journ. Amer. Med. Assoc., 110, 706–709.CrossRefGoogle Scholar
Forel, O. L. (1931), “Le pronostic dans la pratique psychiatrique, son application aux cas de Schizophrenie,” Schweiz. Arch. Neurol. Psychiat., 27, 250–258.Google Scholar
Freudenberg, Rudolf (1938), “Insulin Therapy,” etc., Journ. Ment. Sci., 84, 165.Google Scholar
Fromenty, H. (1937), “Les rémissions dans la schizophrenie, statistique par leur frequence et leur durée avant l'insulin therapie,” L'Encéphale, 1, 275–386.Google Scholar
Fuller, R. G. (1935), “What Happens to Mental Patients after Discharge from Hospital?” Psychiat. Quart., 9, 95–104.CrossRefGoogle Scholar
Gerloff, W. (1937), “Über Verlauf und Prognose der Schizophrenie,” Arch. Psychiat. Nervenkr., 106, 585–598.CrossRefGoogle Scholar
Gillespie, R. D. (1939), “Critical Review: Narcosis Therapy,” Journ. Neurol. Psychiat., 2 (new series), 45, January.CrossRefGoogle ScholarPubMed
Gillman, S. W., and Parfitt, D. N. (1938), “Fits in Schizophrenia,” Lancet, 2, 663.CrossRefGoogle Scholar
Gissane, Blair and Rank, (1940), “Fractures of the Femur in Convulsive Therapy,” ibid., March 8.CrossRefGoogle Scholar
Gjessing, R. (1938), Journ. Ment. Sci., 84, 608.CrossRefGoogle Scholar
Goldstein, H., Dombraski, E. F., and Edlin, J. V. (1938), “Treatment of Psychoses with Pentamethylene-tetrazol,” Amer. Journ. Psychiat., 94, 1347.CrossRefGoogle Scholar
Good, Rankin (1939), “Fracture Dislocation of Humerus due to Convulsion Treatment,” Brit. Med. Journ., 2, 170.Google Scholar
Guelin, L. E., and Cleckley, (1939), “Anomalies and Dangers in the Metrazol Therapy of Schizophrenia,” ibid., 96, 1, 183, July.Google Scholar
Guttmann, Mayer-Gross, and Slater, E. T. O. (1939), “Short Distance Prognosis in Schizophrenia,” Journ. Neur. and Psychiat., 2, No. 1, 25, January.CrossRefGoogle ScholarPubMed
Gyarfas, K. (1934), “Beitrage zur prognostichen Bedeutung der Schizophrenen Prozesssymptome,” Z. ges. Neurol. Psychiat., 150, 740–747.CrossRefGoogle Scholar
Hamsa, W. R., and Bennett, (1939), “Fractures in Metrazol Therapy,” Journ. Amer. Med. Assoc., 112, 501–509.Google Scholar
Harris, A. (1938), “Cardiazol Treatment of Schizophrenia,” Journ. Ment. Sci., September.CrossRefGoogle Scholar
Hecht, D. O. (1905), “A Study of Dementia Praecox,” Journ. Ment. and Nerv. Dis., 32, 689–712 and 763-790.Google Scholar
Hecker, Ewald (1871), “Die Hebephrenia,” Virchow. Archiv, Band 52, Berlin.CrossRefGoogle Scholar
Henderson, and Gillespie, R. D. (1936), Textbook of Psychiatry, 4th ed. Google Scholar
Hinsie, L. E. (1931), “Criticism of Treatment and Recovery in Schizophrenia,” Proc. Assoc. Res. Ment. and Nerv. Dis., 10, 211.Google Scholar
Hoch, (1910), “Constitutional Factors in the Dementia Praecox Group,” Rev. Neurol. Psychiat., August.Google Scholar
Hoffman, E. (1919), “Prognose und Heilung der Dementia Precox,” Monographie Grossenhain in Sacken, 1919, quoted by Langfeldt, G. (1937).Google Scholar
Horwitz, W. A., and Kleinman, C. (1936), “A Survey of Cases of Dementia Praecox Discharged from the Psychiatric Institute and Hospital,” Psychiat. Quart., 10, 72–86.CrossRefGoogle Scholar
Humbert, F., and Friedmann, A. (1937), “Critique and Indications of Treatments in Schizophrenia,” Amer. Journ. Psychiat., 94, supplement on the 1937 Berne-Münsingen Congress, 174–183.CrossRefGoogle Scholar
Humm, D. C. (1937), quoted by Langfeldt, G. (1937), “Mental Disorders in Siblings,” Amer. Journ. Psychiat., 12, 239–283, September, 1932.Google Scholar
James, G. W. B., Freudenberg, R., and Cannon, Tandy (1938), “A Year's Experience of Insulin Therapy in Schizophrenia,” Proc. Roy. Soc. Med., 31, 578, April.CrossRefGoogle ScholarPubMed
Jelliffe, S. E., and White, (1935), “Diseases of the Nervous System,” Textbook of Neurology and Psychiatry. Philadelphia and New York: Lea & Ferbiger.Google Scholar
Ravn, Jorgen (1934), “Sulfosinbehandlung av Schizophrenia,” Nord. Med. Tidsskr., December.Google Scholar
Jung, C. G. (1909), “The Psychology of Dementia Praecox,” Nerv. and Ment. Dis. Monograph Series, No. 3.CrossRefGoogle Scholar
Idem (1939), “The Psychogenesis of Schizophrenia,” Proc. Roy. Soc. Med., 31, April 4.Google Scholar
Kahlbaum, K. (1902), “Zur Kasuistik der Katatonie,” Monatsschr. Psychiat. Neurol., 12, 22–60.CrossRefGoogle Scholar
Kennedy, Alexander (1937), “Convulsion Therapy in Schizophrenia,” Journ. Ment. Sci., November.CrossRefGoogle Scholar
Kerstens, (1938), in a personal communication to Walk and Mayer-Gross.Google Scholar
Kirby, G. H. (1913), “The Catatonic Syndrome and its Relation to Manic-Depressive Insanity,” Journ. Nerv. and Ment. Dis., 40, 694. New York.CrossRefGoogle Scholar
Klaesi, J. (1938), in discussion, Amer. Journ. Psychiat., 94, supplement on the 1937 Berne-Munsingen Congress, May, 335.Google Scholar
Kolle, K. (1928), quoted by Raphael, , Ferguson, and Searle, .Google Scholar
Kraepelin, E. (1919), Dementia Praecox and Paraphrenia, translated by Barclay, Mary. Edinburgh: E. S. Livingstone.Google Scholar
Kraus, G. (1938), Psych. Neur. Bladen, 1, 81.Google Scholar
Kretschmer, E. (1921), Korperbau und Charakter. Berlin.Google Scholar
Kronfeld, A., and Sternberg, E. (1937), “Experiences with Insulin Shock Therapy in Schizophrenia,” Amer. Journ. Psychiat., 94, supplement on the Berne-Munsingen Congress, 276.CrossRefGoogle Scholar
Kuppers, E. (1937), “Die Insulin und Cardiazol Behandlung der Schizophrenia,” Psych. Neur. Wochenschr., 52, 597.Google Scholar
Landis, C. (1937), Concepts and Problems of Psychotherapy, Chapter V. New York.Google Scholar
Langfeldt, E. (1937), “Prognosis in Schizophrenia, and the Factors influencing the Course of the Disease,” Acta Psychiat. u. Neurol., Supplement, 13.Google Scholar
Lehoczky, , Horanyi, , Eszenyi, and Bak, (1939), Lancet, 2, 283, July.CrossRefGoogle Scholar
Lemke, R. (1935), Arch. Psychiat. Nervensskr., 104, 89.CrossRefGoogle Scholar
Leonhard, K. (1936), Die Defektschizophrenen Krankheitsbilder. Georg Thieme: Leipzig (1936).Google Scholar
Levin, H. L. (1931), “Recovery in Dementia Praecox: Report of 35 Cases,” Psychiat. Quart., 5, 476–491.CrossRefGoogle Scholar
Lewis, Aubrey (1935), “Prognosis in Schizophrenia,” Lancet, 1, 339.CrossRefGoogle Scholar
Lewis, N. D. C. (1923), “The Constitutional Factors in Dementia Praecox,” Nerv. and Ment. Dis., Monograph Series No. 35. New York and Washington.Google Scholar
Idem and Blanchard, E. (1931), “Clinical Findings in Recovered Cases of Schizophrenia,” Amer. Journ. Psychiat., 2, 481–492.Google Scholar
Low, et al. (1938), “Metrazol Shock for Psychoses,” Arch. Neurol. Psychiat., 39, 721.CrossRefGoogle Scholar
Luxemberger, H. (1937), “Die Heutige stand der Erbprognose, in der psychiatrische Grundlage fur massnahmen der Praktischen Erbgesundheitspflege,” Zentralbl. f. d. ges. Neur. u. Psychiat., 83, 9.Google Scholar
Malzberg, Benjamin (1938), “Outcome of Insulin Treatment of 1,000 Patients with Dementia Praecox,” Psychiat. Quart., 12, 528–553.Google Scholar
Mapother, , Ed. (1937), “Mental Symptoms Associated with Head Injury,” Brit. Med. Journ., 2, 1055.CrossRefGoogle ScholarPubMed
Marzynski, M. (1938), “Insulin Shock Therapy in Schizophrenia,” Amer. Journ. Psychiat., 94, supplement on the 1937 Berne-Munsingen Congress, 240.CrossRefGoogle Scholar
Mauz, Fr. (1930), Die Prognostik der Engogen Psychosen. Georg Thieme: Leipzig (1930).Google Scholar
May, James V. (1932), “The Dementia-Praecox Schizophrenia Problem,” Psychiat. Quart., 6, 40.CrossRefGoogle Scholar
Gross, Mayer (1932), in Handbuch der Geisteskrankheiten, Bd. IX, “Die Schizophrenie.” J. Springer: Berlin (1932).Google Scholar
Idem (1938), “The Early Diagnosis of Schizophrenia,” Brit. Med. Journ., 2, 936.CrossRefGoogle Scholar
Von Meduna, L. (1935), “Die Konvulsionstherapie der Schizophrenie,” Psychiat. Neurol. Wochenschr., 37, 317–319.Google Scholar
Idem (1937), Die Konvulsionstherapie der Schizophrenie. Marhold.Google Scholar
Idem and Friedman, E. (1939), “The Convulsive Irritative Therapy of the Psychoses,” Journ. Amer. Med. Assoc., 112, 501–509.Google Scholar
Menninger, K. A. (1928), “The Schizophrenic Syndrome as a Product of Acute Infectious Disease,” Proc. Assoc. Res. Ment. and Nerv. Dis., 5, 182 (1932).Google Scholar
Menzies, D. (1935), Lancet, 2, 994.CrossRefGoogle Scholar
Meyer, Adolf (1928), “The Evolution of the Dementia Praecox Concept,” Proc. Assoc. Res. Ment. and Nerv. Dis., 5, 3, Hoeber (1928).Google Scholar
Idem (1929), “Fundamental Conceptions of Dementia Praecox,” Brit. Med. Journ., 1906, September.Google Scholar
Meyer, E. (1909), “Die Prognose der Dementia Praecox,” Arch. Psychiat. Nervenkr., 45, 351–407.CrossRefGoogle Scholar
Idem (1903), “Zur Prognostichen Bedeutung der Katatonischen Erscheinung,” Münch. med. Wochenschr., 50, 1369–1372.Google Scholar
Meynert, (1928), quoted by Menninger, (1928). See above.Google Scholar
Muller, M. (1935), “Die Schizophrenen Erkrankungen. I, Prognose und prophylaxe,” Fortschr. Neurol. Psychiat., 7, 447–474.Google Scholar
Idem (1936), quoted by James, G. W. B., Freudenberg, R., and Cannon, (1938).Google Scholar
Idem (1937), “The Insulin Therapy of Schizophrenia,” Amer. Journ. Psychiat., 94, supplement on Proc. of Munsingen Congress (May, 1938).Google Scholar
Myerson, A. (1936), quoted by Henderson, and Gillespie, .Google Scholar
Idem (1917), “Psychiatric Family Studies,” Amer. Journ. Insan. Ball., 1, 23, 355.Google Scholar
Nightingale, G. S. (1938), Journ. Ment. Sci., 84, 574.Google Scholar
Notkin, J., and Dentale, F. J. (1938), “Statistical Recoveries between Pre-Insulin and Insulin Eras,” Psychiat. Quart., 12, 432–443.CrossRefGoogle Scholar
Otha, K. (1937), Zentralbl. Neur. Psychiat., 84, 282.Google Scholar
Otto-Martiensen, J. (1921), Allg. Zeitschr. Psychiat., 77, 295.Google Scholar
Oxford Dictionary (The Concise) (1939), 3rd edition, p. 990.Google Scholar
Palmer, H. A. (1939), “Vertebral Fractures Complicating Convulsion Therapy,” Lancet, 2, 181, July.CrossRefGoogle Scholar
Pameijer, J. H. (1938), “Treatment of Schizophrenia,” discussion, Journ. Ment. Sci., 84, 689.Google Scholar
Polatin, , Friedman, , Harris, and Horwitz, (1939), “Vertebral Fractures Produced by Metrazol Induced Convulsions,” Journ. Amer. Med. Assoc., 112, 1684.CrossRefGoogle Scholar
Pollock, H. M. (1925), “Outcome of Mental Diseases in the United States,” Mental Hygiene, 9, 783–804.Google Scholar
Idem (1928), “Frequency of Schizophrenia in Relation to Sex, Age, Environment, Maturity and Race,” Proc. Assoc. Res. Ment. and Nerv. Dis., 5, 47.Google Scholar
Idem (1939), “A Statistical Study of 1,140 Dementia Praecox Cases Treated with Metrazol,” Psychiat. Quart., 553, July.Google Scholar
Raecke, (1910), “Zur Prognose der Katatonie,” Arch. Psychiat. Nervenkr., 47, 1–26.CrossRefGoogle Scholar
Raphael, I., Ferguson, W. C., and Searle, O. M. (1928), “Constitutional Factors in Schizophrenia,” Proc. Assoc. Res. Ment. and Nerv. Dis., 5, 100.Google Scholar
Reitman, Francis (1939), “Cardiazol Therapy in Schizophrenia,” Lancet, 1, 439, February.CrossRefGoogle Scholar
Roemer, Hans (1938), “The New Methods of Treatment of Schizophrenia,” Amer. Journ. Psychiat., 94, 235, supplement on 1937 Berne-Munsingen Congress.CrossRefGoogle Scholar
Rosanoff, A. J. (1914), “A Statistical Study of Prognosis in Insanity,” Journ. Amer. Med. Assoc., 62, 3.CrossRefGoogle Scholar
Idem (1931), Amer. Journ. Psychiat., 2, 289.Google Scholar
Idem (1932), “Twins Study in Certain Mental Disorders,” California and Western Med., 37, 101–105.Google Scholar
Rüdin, (1936), quoted by Henderson, and Gillespie, , p. 33, Textbook of Psychiatry. Google Scholar
Idem (1916), Studien über Vererbung und Enstehung der Gestiger Aorungen. Berlin: Julius Springer.Google Scholar
Sakel, Manfred (1935), Neue Behandlungsmethode der Schizophrenie. Vienna and Leipzig.Google Scholar
Savitt, Robert A. (1938), “Some Comparisons of Insulin Treated and Non-insulin Treated Cases of Schizophrenia,” Psychiat. Quart., 12, 426–431.CrossRefGoogle Scholar
Schaeffer, H. (1938), “Le pronostic de la Schizophrenie,” Presse Méd., 46, 470–473.Google Scholar
Schmidt, H. (1911), “Ergebnisse persönlicher erhobener Katamnese bei geheilten Dementia Praecox Kranken,” Z. ges. Neurol. Psychiat., 6, 125–195.CrossRefGoogle Scholar
Somers, D., and Richardson, R. P. (1939), Amer. Journ. Psychiat., 95, 5, 1193, March.CrossRefGoogle Scholar
Stalker, H. (1938), “Double Vertebral Fracture from Convulsion Treatment,” Lancet, 2, 1172.CrossRefGoogle Scholar
Idem , Millar, W. M., and Jacobs, J. M. (1939), “Remissions in Schizophrenia,” ibid., February, 437.Google Scholar
Stearne, A. W. (1912), “Prognosis in Schizophrenia,” Boston Med. and Surg. Journ., 167, 758–760, August.Google Scholar
Stokes, A. B. (1939), “Critical Review: Somatic Research in Periodic Catatonia,” Journ. Neurol. Psychiat., 2, 243 (new series), July, 1939.CrossRefGoogle ScholarPubMed
Strauss, E. B. (1931), “Some Principles underlying Prognosis in Schizophrenia,” Proc. Roy. Soc. Med., 24, 1217–1222.CrossRefGoogle ScholarPubMed
Strecker, E. A. (1931), “Prognosis in Schizophrenia,” Proc. Assoc. Res. Ment. and Nerv. Dis., 10, 119.Google Scholar
Idem and Willey, G. F. (1924), “An Analysis of Recoverable Dementia Praecox Reactions,” Amer. Journ. Psychiat., 3, 4, 593–677, April.Google Scholar
Strecker, , Pullar, H. (1938), “Insulin Treatment of Schizophrenia,” Journ. Ment. Sci., 84, 154, January CrossRefGoogle Scholar
Sullivan, H. S. (1928), “Tentative Criteria of Malignancy in Schizophrenia,” Amer. Journ. Psychiat., 7, 759–787.CrossRefGoogle Scholar
Idem (1931), “The Relation of Onset to Outcome in Schizophrenia,” Proc. Assoc. Res. Ment. and Nerv. Dis., 10, p. 111 Google Scholar
Taylor, James A., and Von Salzen, C. F. (1938), “Prognosis in Schizophrenia,” Psychiat. Quart. 12, 576–582.CrossRefGoogle Scholar
Thomas, , Lees, W., and Wilson, I. G. H. (1938), Board of Control Report on Cardiazol Treatment and the Present Application of Hypoglycæmic Shock Treatment in Schizophrenia. Published by H.M. Stationery Office.Google Scholar
Tooth, G., and Blackburn, J. M. (1939), “Disturbances of Memory after Convulsion Treatment,” Lancet, 1, 17, July 1.CrossRefGoogle Scholar
Walk, A., and Mayer-Gross, W. (1938), “Observations on Convulsion Treatment with Triazol 156,” Journ. Ment. Sci., 84, 637–663.CrossRefGoogle Scholar
Wespi, H. (1938), Schweiz. Arch. Neurol. Psychiat., 42, 404.Google Scholar
Whitehead, D. (1937), “Prognosis in Dementia Praecox,” Psychiat. Quart., 11, 383–390.CrossRefGoogle Scholar
Idem (1938), “Improvement and Recovery Rates in Dementia Praecox without Insulin Therapy,” ibid., 12, 409–413.Google Scholar
Williams, P. R., and Potter, H. W. (1921), “The Significance of Certain Symptoms in the Prognosis of Dementia Praecox,” State Hosp. Quart., 6, 361–480.Google Scholar
Wilson, Isabel G. H. (1937), “A Study of Hypoglycaemic Shock Treatment in Schizophrenia,” Board of Control Report. H.M. Stationery Office.Google Scholar
Winkelman, N. W. (1938), “Mctrazol Treatment of Schizophrenia,” Amer. Journ. Psychiat., 95, 303–316, September.CrossRefGoogle Scholar
Wootton, L. H., Armstrong, R. W., and Lilley, D. (1935), “After Histories of Discharged Mental Patients,” Journ. Ment. Sci., 81, 168–172.Google Scholar
Zilboorg, G. (1928), “Malignant Psychoses Related to Childbirth,” Amer. Journ. Obstet. and Gynaec., 15, 154–158.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.